ClinicalTrials.govpublic full text
A Single-arm Clinical Trial of IMGN853 in Chinese Adult Patients With Platinum-resistant, Epithelial Ovarian Cancer
epithelial ovarian cancer, peritoneal cancer, fallopian tube cancer, platinum resistant, folate-receptor alpha expression, phase 3, antibody-drug conjugate, mirvetuximab soravtansine, imgn853, mirv, frα, interventional
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 831793
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.